Related Experiment Video
Updated: Feb 5, 2026

Author Spotlight: Investigating Fungal Pathogenicity Mechanisms in Maize
Published on: September 15, 2023
Top-ten papers in fungal infection (2015-2017)
P Puerta-Alcalde1, C Cardozo, A Soriano
1Pedro Puerta-Alcalde, MD. Infectious Diseases Department, Hospital Clínic; Carrer Villarroel 170, 08036, Barcelona, Spain. pedro.puerta84@gmail.com.
Abstract:
We have clustered the published articles in fungal infection between 2016 and 2017 in four categories. First, the emergence of Candida auris as a nosocomial pathogen associated to high antifungal resistance and high mortality. Second, the growing importance of fungal infections associated to the use of biologic therapies. Third, the approval of isavuconazole for the treatment of filamentous fungi and dymorphic mycoses with positive results and less side effects. And finally, a mix of other important news regarding empiric therapy, fluconazole toxicity and difficult-to-treat fungal infections..
Insights
Recent fungal infection research highlights the rise of Candida auris, a resistant pathogen, and the impact of biologic therapies. New treatments like isavuconazole show promise for difficult fungal infections.
Area of Science:
- Mycology
- Infectious Diseases
- Clinical Research
Background:
- Fungal infections pose significant global health challenges.
- Antifungal resistance and treatment-related infections are growing concerns.
Purpose of the Study:
- To categorize and summarize key developments in fungal infection research from 2016-2017.
- To identify emerging trends and significant findings in mycology.
Main Methods:
- Systematic review and clustering of published articles on fungal infections.
- Analysis of trends in pathogen emergence, treatment modalities, and therapeutic outcomes.
Main Results:
- Identified Candida auris as a critical nosocomial pathogen with high resistance and mortality.
- Highlighted increased fungal infections linked to biologic therapies.
- Noted the approval and efficacy of isavuconazole for specific fungal infections.
- Summarized advancements in empiric therapy and management of challenging fungal cases.
Conclusions:
- The landscape of fungal infections is rapidly evolving, demanding attention to emerging pathogens and novel therapeutic strategies.
- Continued research is crucial for combating antifungal resistance and improving patient outcomes.
Related Concept Videos
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Fungal Phylum Ascomycota
Fungal Phylum Basidiomycota
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Stages of Infection

